FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 93 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,296,000 | +220.0% | 64,945 | +10.6% | 0.00% | +100.0% |
| Q2 2022 | $405,000 | 0.0% | 58,732 | +34.9% | 0.00% | 0.0% |
| Q1 2022 | $405,000 | -36.6% | 43,550 | -3.1% | 0.00% | 0.0% |
| Q4 2021 | $639,000 | -37.9% | 44,923 | +1.2% | 0.00% | 0.0% |
| Q3 2021 | $1,029,000 | -2.7% | 44,391 | +4.4% | 0.00% | 0.0% |
| Q2 2021 | $1,058,000 | +20.5% | 42,516 | +35.7% | 0.00% | 0.0% |
| Q1 2021 | $878,000 | +26.9% | 31,340 | +58.0% | 0.00% | 0.0% |
| Q4 2020 | $692,000 | -21.3% | 19,834 | +12.5% | 0.00% | 0.0% |
| Q3 2020 | $879,000 | – | 17,633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,529 | $43,866,000 | 8.09% |
| Logos Global Management LP | 1,410,000 | $39,508,000 | 3.86% |
| RA Capital Management | 9,011,651 | $252,506,000 | 3.81% |
| Cormorant Asset Management, LP | 4,720,000 | $132,254,000 | 2.95% |
| Artal Group S.A. | 1,000,000 | $28,020,000 | 0.50% |
| Perceptive Advisors | 1,250,000 | $35,025,000 | 0.44% |
| HighVista Strategies LLC | 20,630 | $578,000 | 0.43% |
| HHLR ADVISORS, LTD. | 1,100,000 | $30,822,000 | 0.30% |
| Baker Brothers Advisors | 2,024,876 | $56,737,000 | 0.25% |
| Tekla Capital Management LLC | 149,825 | $4,198,000 | 0.14% |